Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
about
Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.Aggression in autism spectrum disorder: presentation and treatment optionsNeuropathological Mechanisms of Seizures in Autism Spectrum DisorderAtopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disordersCardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative StressCognitive remission: a novel objective for the treatment of major depression?Pharmacological treatments for methamphetamine addiction: current status and future directions.A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia.Protective Effect of N-Acetylcysteine Amide on Blast-Induced Increase in Intracranial Pressure in Rats.N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.Glutamatergic agents for OCD and related disordersN-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms.N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice.A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.Pituitary Adenylate cyclase-activating polypeptide orchestrates neuronal regulation of the astrocytic glutamate-releasing mechanism system xc (.).In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state.Management of obsessive-compulsive disorder comorbid with bipolar disorder.Treating Addiction: Unraveling the Relationship Between N-acetylcysteine, Glial Glutamate Transport, and Behavior.N-Acetyl-L-cysteine Protects the Enterocyte against Oxidative Damage by Modulation of Mitochondrial FunctionWide range of age of onset and low referral rates to psychiatry in a large cohort of acne excoriée at a Swiss tertiary hospital.Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.Sleep and Psychiatric Disorders in Persons With Mild Traumatic Brain Injury.Recent developments in the behavioural and pharmacological enhancement of extinction of drug seeking.The Neuroprotective Effect of Conditioned Medium from Human Adipose-Derived Mesenchymal Stem Cells is Impaired by N-acetyl Cysteine Supplementation.Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug AbuseTargeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.Improvement in Excoriation (Skin-Picking) with use of Risperidone in a Patient with Developmental DisabilityChronic methamphetamine self-administration disrupts cortical control of cognition.New drug developments in psychosis: Challenges, opportunities and strategies.The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use DisordersTrichotillomania as a Manifestation of Dementia.Cognitive effects of adjunctive N-acetyl cysteine in psychosis.New Assessments and Treatments in ASD.Amino Acid Catabolism in Alzheimer's Disease Brain: Friend or Foe?Glutathione as a Redox Biomarker in Mitochondrial Disease-Implications for Therapy.The Pivotal Role of Aldehyde Toxicity in Autism Spectrum Disorder: The Therapeutic Potential of Micronutrient Supplementation.Mitochondrial Dysfunction in Psychiatric Illness.The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: A randomized, double-blind, placebo-controlled trial.Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.What Should We Tell Our Patients About Marijuana (Cannabis indica and Cannabis sativa)?
P2860
Q26744037-19CC4806-7179-4C84-9CF1-7DF5797B9C63Q26744346-BF6595B1-B615-4C26-AD9F-9AE42625FF48Q26744759-BD40C855-E207-49BF-8110-E23B58E6BD23Q26746354-6DA8FFA0-0D50-4751-A988-5A6C04E685ADQ26773004-90C6980E-9428-41FD-96EB-588479286506Q26775386-6598DB4A-F047-4ED4-B4DA-24BFE96E790BQ30240173-10B0B276-82B4-43D3-BBB3-FC1419AFEC60Q33624417-CE05B167-37AD-46C1-A932-08C877D50A3FQ33766357-2D7C4DF4-EB64-461D-AB72-5943E60EF8A2Q34543171-796E2415-0C1F-4E1C-A5CE-6DA31ED6AFBEQ35967025-83602A62-3515-4D2A-9E7E-86DB831FBCD0Q36133400-5691A20B-2B48-4B23-A6E1-5CFA7975D39BQ36761238-AB83B9FB-353D-427D-99FC-CF49DC6EB760Q36820394-52095A5F-22EB-4B91-9F63-DD13FAD3DB0BQ36930072-E0F487AF-9A07-4714-A9F4-8EC47D4942ADQ37361055-B7C001A6-EBF6-4FF6-9722-2523B838B5D7Q37400532-518B8BFD-3992-4564-B95B-5ADF39F68451Q37458157-B41AB987-985A-46AE-A2C2-FF97DF190863Q37492578-DE5A956D-C5ED-4988-B589-05F9B0DDCC46Q38636662-32C11390-0897-4585-B0F3-E5328641DD29Q38647035-F4B43E7C-FA46-46FF-9813-C58615201E0DQ38666333-10C0187A-82B4-497D-AA0B-6E2C152DE645Q38674558-47E28AC1-0B75-4058-B4E1-4D3347B078C2Q38694814-1D1A28D9-6EC8-4207-8E9F-3322DF4BBA2EQ38729846-CD6CDC14-E69A-4486-B1B9-F35511621990Q38748531-286F6B72-7D75-41BF-8C9F-9520BABC2EE7Q38823927-C2214D94-9DB3-4CF7-8F6F-DE614F33D9EAQ38906406-AD25E008-27AC-4612-9A27-86CA72F41F29Q38926246-3BB40644-211D-4354-AF2A-25C538E26289Q38950639-9DF494D5-3B9F-4544-A744-D794442AB3BFQ39007398-D92834BE-C73C-454C-BDDE-B19BE6FC9E19Q39147992-17723743-5A31-460B-BCF5-1F991AE43E70Q39157674-89EFB2C4-DB9C-4779-A89E-DF37BA92DF5AQ39162716-2A6329CB-F7D6-4F28-83DB-01E66C2764DDQ39280494-F2375719-08DC-44FE-A93D-C9DA0530E1BEQ41913940-3A61E5DD-7E97-46E7-B0F7-E440849BA410Q42406400-200858AD-46E3-484E-868A-B4B843F4C56EQ42701956-D9E1E96B-FCE4-4EFA-BBC5-5AC1797D8DC9Q42870393-A36EDC81-A5D9-426C-8393-591FB5051B72Q44606583-A64CE033-5E5C-4D58-8F61-2DF8455DEA16
P2860
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
@ast
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
@en
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
@nl
type
label
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
@ast
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
@en
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
@nl
prefLabel
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
@ast
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
@en
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
@nl
P2093
P1476
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
@en
P2093
Charles Spielholz
John Slattery
Leanna Delhey
Nihit Kumar
Olivia Dean
Richard Frye
P304
P356
10.1016/J.NEUBIOREV.2015.04.015
P50
P577
2015-05-06T00:00:00Z